BER genes expression in oral and pre-oral cancer: Combinatorial approach to propose potential biomarker [0.03%]
口腔和口前部癌症中BER基因表达：组合方法提出潜在生物标志物
Kumud Nigam,Yogendra Verma,Manish Dwivedi et al.
Kumud Nigam et al.
Objective: DNA repair genes and their variants have been found to alter the risk of oral cancer. Method: The level of expression of XRC...
A combined model using pre-treatment CT radiomics and clinicopathological features of non-small cell lung cancer to predict major pathological responses after neoadjuvant chemoimmunotherapy [0.03%]
基于新辅助化疗免疫治疗前CT影像组学和临床病理特征的非小细胞肺癌疗效预测模型研究
Fang Wang,Hong Yang,Wujie Chen et al.
Fang Wang et al.
Objective: To investigate the relationship between clinical pathological characteristics, pretreatment CT radiomics, and major pathologic response (MPR) of non-small cell lung cancer (NSCLC) after neoadjuvant chemoimmunot...
Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis [0.03%]
三阴性乳腺癌新辅助治疗中铂类药物剂量的系统评价和网状Meta分析
Fausto Petrelli,Antonio Ghidini,Carmen Rea et al.
Fausto Petrelli et al.
Introduction: There are multiple neoadjuvant regimens, including platinum agents for triple-negative breast cancer (TNBC), each with a different safety profile, outcome, and pathologic complete response rate (pCR%). We pe...
Shan Gao,Yu-Tong Wang,Guang-Yu Ma et al.
Shan Gao et al.
Background: A solitary plasmacytoma is classified into a solitary plasmacytoma of the bone (SBP) and a solitary extramedullary (soft tissue mass) plasmacytoma, based on the site of the lesion. Despite the high local contr...
Borderline tumours of ovary and fertility preservation-Outcomes from a tertiary care center in India [0.03%]
borderline肿瘤与生育保留：印度三级医疗中心的随访结果分析
Sarita Kumari,Neerja Bhatla,Chandrima Ray et al.
Sarita Kumari et al.
Objective: Borderline ovarian tumors (BOT) are characterized by atypical epithelial proliferation without stromal invasion and majority are diagnosed in women of reproductive age group desirous of fertility preservation. ...
Cancer genetics and treatment rift: Perspectives for coping challenges in low and middle-income countries [0.03%]
癌症遗传学和治疗分歧：应对低收入和中等收入国家挑战的展望
Sonali Deore,Prassana Deshpande,Jitendra Bhawalkar et al.
Sonali Deore et al.
Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data [0.03%]
来那度胺/地塞米松联合用药治疗美国复发和/或难治性多发性骨髓瘤的疗效：基于真实世界电子健康记录数据的分析
Sikander Ailawadhi,Mu Cheng,Dasha Cherepanov et al.
Sikander Ailawadhi et al.
Background: This retrospective longitudinal study compared the effectiveness of dexamethasone+lenalidomide (Rd)-based triplet regimens containing proteasome inhibitors (PIs) ixazomib (IRd), carfilzomib (KRd), and bortezom...
Comparative Study
Current problems in cancer. 2024 Jun:50:101078. DOI:10.1016/j.currproblcancer.2024.101078 2024
Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis [0.03%]
塞利尼索治疗复发难治多发性骨髓瘤患者的疗效和安全性：一项系统评价和 Meta 分析
Laila Shafei,Shaima Bashir,Esther W Chan et al.
Laila Shafei et al.
Purpose: Selinexor is a first-in-class, oral selective-inhibitor-of-nuclear-export, granted accelerated approval by FDA (2019) for relapsed and refractory multiple myeloma (RRMM). We sought to quantitatively summarize the...
Go Nishikawa,Mark A Klein
Go Nishikawa
Rearranged during transfection (RET) alterations, which lead to aberrant activation of the RET proto-oncogene, have been identified in various cancers. In non-small cell lung cancer (NSCLC), RET mutations often manifest as RET fusion genes ...
Development and validation of nomogram models for predicting postoperative prognosis of early-stage laryngeal squamous cell carcinoma [0.03%]
用于预测早期喉鳞状细胞癌术后预后的列线图模型的建立与验证
Xu Juan,Huang Jiali,Liu Ziqi et al.
Xu Juan et al.
Background: We aimed to investigate the postoperative prognosis in patients with early-stage laryngeal squamous cell carcinoma (LSCC) in association with the preoperative blood markers and clinicopathological characterist...